GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » EV-to-EBITDA

AegirBio AB (AegirBio AB) EV-to-EBITDA : -2.02 (As of May. 24, 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, AegirBio AB's enterprise value is $5.18 Mil. AegirBio AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.56 Mil. Therefore, AegirBio AB's EV-to-EBITDA for today is -2.02.

The historical rank and industry rank for AegirBio AB's EV-to-EBITDA or its related term are showing as below:

AEGBF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -169.58   Med: -1.63   Max: 0.03
Current: -1.99

During the past 4 years, the highest EV-to-EBITDA of AegirBio AB was 0.03. The lowest was -169.58. And the median was -1.63.

AEGBF's EV-to-EBITDA is ranked worse than
100% of 486 companies
in the Medical Devices & Instruments industry
Industry Median: 16.14 vs AEGBF: -1.99

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), AegirBio AB's stock price is $0.11. AegirBio AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.163. Therefore, AegirBio AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


AegirBio AB EV-to-EBITDA Historical Data

The historical data trend for AegirBio AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB EV-to-EBITDA Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
- -24.05 -11.89 -0.10

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.11 -0.09 -0.12 -2.14

Competitive Comparison of AegirBio AB's EV-to-EBITDA

For the Medical Devices subindustry, AegirBio AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AegirBio AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AegirBio AB's EV-to-EBITDA falls into.



AegirBio AB EV-to-EBITDA Calculation

AegirBio AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5.177/-2.561
=-2.02

AegirBio AB's current Enterprise Value is $5.18 Mil.
AegirBio AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AegirBio AB  (GREY:AEGBF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AegirBio AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.11/-0.163
=At Loss

AegirBio AB's share price for today is $0.11.
AegirBio AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.163.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


AegirBio AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AegirBio AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines